Anondita Medicare Ltd
Founded in March 2024, Anondita Medicare Limited manufactures flavored male condoms, with its flagship product branded as “COBRA.”[1]
- Market Cap ₹ 2,041 Cr.
- Current Price ₹ 1,129
- High / Low ₹ 1,316 / 262
- Stock P/E 61.0
- Book Value ₹ 71.5
- Dividend Yield 0.00 %
- ROCE 43.6 %
- ROE 40.0 %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 15.8 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Fast Moving Consumer Goods Fast Moving Consumer Goods Personal Products Personal Care
Part of Nifty SME Emerge
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| 77 | 137 | |
| 51 | 87 | |
| Operating Profit | 26 | 51 |
| OPM % | 33% | 37% |
| 0 | 1 | |
| Interest | 3 | 4 |
| Depreciation | 1 | 1 |
| Profit before tax | 22 | 47 |
| Tax % | 25% | 27% |
| 16 | 34 | |
| EPS in Rs | 11.88 | 18.49 |
| Dividend Payout % | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 78% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 112% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 40% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Equity Capital | 13 | 18 |
| Reserves | 25 | 111 |
| 27 | 34 | |
| 13 | 22 | |
| Total Liabilities | 78 | 185 |
| 14 | 84 | |
| CWIP | 6 | 0 |
| Investments | 3 | 0 |
| 55 | 101 | |
| Total Assets | 78 | 185 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| -10 | 11 | |
| -23 | -63 | |
| 33 | 61 | |
| Net Cash Flow | -0 | 9 |
| Free Cash Flow | -30 | -52 |
| CFO/OP | -38% | 28% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Debtor Days | 127 | 138 |
| Inventory Days | 141 | 126 |
| Days Payable | 40 | 49 |
| Cash Conversion Cycle | 228 | 215 |
| Working Capital Days | 129 | 163 |
| ROCE % | 44% |
Insights
In beta| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Annual Production Volume lakhs pieces |
|
|||
| Capacity Utilization Rate % |
||||
| Installed Production Capacity lakhs pieces |
||||
| Number of Distributors number |
||||
| Number of Retailers number |
||||
| Number of Super Stockists number |
||||
| Total Manufacturing Lines number |
||||
Extracted by Screener AI
Documents
Announcements
-
Giving guarantees/indemnity/ becoming a surety for third party
21 July 2026 - Anondita Medicare issued ₹5 crore corporate guarantee to HDFC Bank for subsidiary AHRPIL on July 21, 2026.
-
Analysts/Institutional Investor Meet/Con. Call Updates
13 July 2026 - Company held in-person investor meet in Mumbai on July 11, 2026; no UPSI shared.
-
Reply to Clarification- Financial results
9 July 2026 - Company clarifies FY26 results query; revised EPS 11.38/20.77 filed May 29, 2026.
-
Analysts/Institutional Investor Meet/Con. Call Updates
8 July 2026 - Anondita Medicare schedules in-person investor meeting in Mumbai on 11 July 2026.
-
Allotment of Securities
8 July 2026 - Anondita Medicare Limited has informed regarding allotment of 285000 Convertible Warrants on Preferential basis at its meeting held on July 08, 2026
Annual reports
No data available.
Concalls
-
Jun 2026TranscriptAI SummaryPPT
-
May 2026Transcript PPT
-
Mar 2026TranscriptAI SummaryPPT
Business Profile:[1]
Anondita Medicare manufactures male (and recently, female) condoms, flagship brand “COBRA,” with in-house printing/packaging and 100% electronic testing.